Masato Kubo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Masato Kubo has a total of 308 co-authors. Here are the top co-authors by number of shared publications:
Yasuyo Harada
Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science , Chiba
8 shared publicationsKosuke Miyauchi
Laboratory for Infectious Diseases and Immunology, Center for Integrative Medical Sciences, RIKEN , Yokohama
6 shared publicationsSewon Ki
Laboratory for Cytokine Regulation, Center for Integrative Medical Sciences, RIKEN , Yokohama
5 shared publicationsYoshie Suzuki
Laboratory for Cytokine Regulation, Center for Integrative Medical Sciences, RIKEN , Yokohama
5 shared publicationsHideki Ueno
Department of Immunology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku , Kyoto 606-8501
4 shared publicationsTakanori Sasaki
Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science , Chiba
4 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Wiley in Immunological Reviews
- Vol. 341 (1) , e70148
The Role of CD4 T Cell Repertoire and Immune Memory Mechanisms in Vaccination and Infection Immunity
CD4 + T cells orchestrate adaptive immunity against respiratory viruses through functionally distinct subsets, yet the qualitative differences between vaccine‐ and infection‐induced responses remain incompletely understood. This review summarizes current evidence on how CD4 + T cell subsets shape the magnitude, breadth, and durability of immunity to SARS‐CoV‐2 and influenza virus. mRNA vaccines elicit a potent Th1/Tfh1‐biased response that generates high‐affinity neutralizing antibodies and cytotoxic CD4 + T cells (CD4‐CTLs) with stem‐cell memory properties. However, this strong type I bias may come at the cost of long‐term maintenance of humoral memory. Natural infection additionally establishes tissue‐resident memory CD4 + T cells (CD4 TRMs) at respiratory mucosal surfaces, providing a frontline defense that current intramuscular vaccines fail to recapitulate efficiently. Crucially, this T cell immunity proves far more resilient than neutralizing antibodies against Variants of Concern, as many memory T cell epitopes from the ancestral strain are conserved across successive variants, a robustness further reinforced by pre‐existing cross‐reactive CD4 + T cells primed through prior seasonal coronavirus exposure or influenza infection. These observations argue for a fundamental shift in vaccine design toward mucosal delivery and conserved‐epitope antigens to achieve durable, broadly cross‐reactive protection.
- 28 July 2026
- Published by Wiley in Immunological Reviews
- Vol. 341 (1) , e70148
Open AccessThe Role of CD4 T Cell Repertoire and Immune Memory Mechanisms in Vaccination and Infection Immunity
CD4 + T cells orchestrate adaptive immunity against respiratory viruses through functionally distinct subsets, yet the qualitative differences between vaccine‐ and infection‐induced responses remain incompletely understood. This review summarizes current evidence on how CD4 + T cell subsets shape the magnitude, breadth, and durability of immunity to SARS‐CoV‐2 and influenza virus. mRNA vaccines elicit a potent Th1/Tfh1‐biased response that generates high‐affinity neutralizing antibodies and cytotoxic CD4 + T cells (CD4‐CTLs) with stem‐cell memory properties. However, this strong type I bias may come at the cost of long‐term maintenance of humoral memory. Natural infection additionally establishes tissue‐resident memory CD4 + T cells (CD4 TRMs) at respiratory mucosal surfaces, providing a frontline defense that current intramuscular vaccines fail to recapitulate efficiently. Crucially, this T cell immunity proves far more resilient than neutralizing antibodies against Variants of Concern, as many memory T cell epitopes from the ancestral strain are conserved across successive variants, a robustness further reinforced by pre‐existing cross‐reactive CD4 + T cells primed through prior seasonal coronavirus exposure or influenza infection. These observations argue for a fundamental shift in vaccine design toward mucosal delivery and conserved‐epitope antigens to achieve durable, broadly cross‐reactive protection.
- Open Access
- 23 July 2026
- Published by Wiley in Barrier Immunity
- Vol. 2 (2) , 95-103
A Role of the IL‐13 Signal and Type 2 Conventional Dendritic Cell in the Atopic March
Allergic diseases such as atopic dermatitis (AD), asthma, and food allergy originate at epithelial barrier surfaces, where environmental insults trigger immune responses. This review emphasizes the crucial role of epithelium‐derived alarmins, especially IL‐33 and TSLP, as innate danger signals (DAMPs) that establish a local type 2 milieu driving type 2 helper T (Th2) immunity. When the barrier is disrupted, local antigen presentation typically drives specific immunity; however, with severe barrier disruption, the local type 2 milieu influences immunity not only locally but also systemically, enabling distant secondary lymphoid organs (SLOs) to develop dendritic cell (DC)‐mediated Type 2 immunity and high‐affinity IgE production. Recent advances in single‐cell transcriptomics have shown that conventional dendritic cell type 2 (cDC2s) are not a single homogeneous group but consist of distinct lineages, T‐bet + cDC2A and T‐bet − cDC2B, with different developmental origins and immune functions. Notably, CD301b + cDC2 (similar to cDC2B) expresses IL‐13 receptor alpha 1 (IL‐13Rα1). Importantly, IL‐13 signaling enhances the antigen‐presenting capacity of CD301b + cDC2, thereby supporting both Th2 and T follicular helper (TFH) responses, leading to high‐affinity IgE production and systemic anaphylaxis. These observations provide a mechanistic understanding of how local skin inflammation can trigger systemic allergic reactions and open new possibilities for targeted immunotherapy focused on the IL‐13–DC axis.
- 23 July 2026
- Published by Wiley in Barrier Immunity
- Vol. 2 (2) , 95-103
Open AccessA Role of the IL‐13 Signal and Type 2 Conventional Dendritic Cell in the Atopic March
Allergic diseases such as atopic dermatitis (AD), asthma, and food allergy originate at epithelial barrier surfaces, where environmental insults trigger immune responses. This review emphasizes the crucial role of epithelium‐derived alarmins, especially IL‐33 and TSLP, as innate danger signals (DAMPs) that establish a local type 2 milieu driving type 2 helper T (Th2) immunity. When the barrier is disrupted, local antigen presentation typically drives specific immunity; however, with severe barrier disruption, the local type 2 milieu influences immunity not only locally but also systemically, enabling distant secondary lymphoid organs (SLOs) to develop dendritic cell (DC)‐mediated Type 2 immunity and high‐affinity IgE production. Recent advances in single‐cell transcriptomics have shown that conventional dendritic cell type 2 (cDC2s) are not a single homogeneous group but consist of distinct lineages, T‐bet + cDC2A and T‐bet − cDC2B, with different developmental origins and immune functions. Notably, CD301b + cDC2 (similar to cDC2B) expresses IL‐13 receptor alpha 1 (IL‐13Rα1). Importantly, IL‐13 signaling enhances the antigen‐presenting capacity of CD301b + cDC2, thereby supporting both Th2 and T follicular helper (TFH) responses, leading to high‐affinity IgE production and systemic anaphylaxis. These observations provide a mechanistic understanding of how local skin inflammation can trigger systemic allergic reactions and open new possibilities for targeted immunotherapy focused on the IL‐13–DC axis.
- Open Access
- 17 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (29) , eaec7827
A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines
Lipid nanoparticle–encapsulated mRNA (mRNA-LNP) vaccines trigger the potent differentiation of antigen-specific cytotoxic CD8 T cells in addition to antibody production. Despite its high immunogenicity, the cellular mechanisms by which mRNA-LNP induces such unusual immune responses remain largely unclear. Here, we show that mRNA-LNP induces potent and long-lasting CD8 T cell expansion through an antigen presentation mechanism that differs from that of conventional adjuvants. In mice immunized with mRNA-LNP, the number of antigen-specific CD8 T cells was one order of magnitude higher than that induced by combining antigen proteins with immunostimulants such as lipopolysaccharide or polyinosinic:polycytidinic acid. Intramuscularly administered mRNA-LNPs were mainly taken up by migratory type 2 conventional dendritic cells in draining lymph nodes, resulting in notably strong and persistent antigen presentation through major histocompatibility complex class I. Furthermore, CD8 T cell induction by mRNA-LNP required migratory dendritic cells but not the traditional cross-presentation pathway that is otherwise essential for antiviral and antitumor immunity. Thus, the mRNA-LNP formulation exerts unconventional immune responses through a different antigen-presentation pathway from conventional component vaccines.
- 17 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (29) , eaec7827
Open AccessA distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines
Lipid nanoparticle–encapsulated mRNA (mRNA-LNP) vaccines trigger the potent differentiation of antigen-specific cytotoxic CD8 T cells in addition to antibody production. Despite its high immunogenicity, the cellular mechanisms by which mRNA-LNP induces such unusual immune responses remain largely unclear. Here, we show that mRNA-LNP induces potent and long-lasting CD8 T cell expansion through an antigen presentation mechanism that differs from that of conventional adjuvants. In mice immunized with mRNA-LNP, the number of antigen-specific CD8 T cells was one order of magnitude higher than that induced by combining antigen proteins with immunostimulants such as lipopolysaccharide or polyinosinic:polycytidinic acid. Intramuscularly administered mRNA-LNPs were mainly taken up by migratory type 2 conventional dendritic cells in draining lymph nodes, resulting in notably strong and persistent antigen presentation through major histocompatibility complex class I. Furthermore, CD8 T cell induction by mRNA-LNP required migratory dendritic cells but not the traditional cross-presentation pathway that is otherwise essential for antiviral and antitumor immunity. Thus, the mRNA-LNP formulation exerts unconventional immune responses through a different antigen-presentation pathway from conventional component vaccines.
- 22 October 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (3) , 185-196
mTORC1-independent IgA production: a unique pathway for gut immune homeostasis
The mammalian target of rapamycin (mTOR) complex 1 (mTORC1) regulates various cellular processes, including immune responses. Previous studies have demonstrated that mTORC1 plays a crucial role in B cell differentiation and the production of IgM and IgG antibodies in response to foreign antigens. However, its role in steady-state antibody production remains poorly understood. In this study, we found that RaptorB−/− mice, which have a B cell-specific deletion of Raptor (an essential component of mTORC1), retained gut-associated IgA production. Conversely, IgM and IgG subclasses were virtually absent due to the loss of peripheral IgM+ mature B cells. We also found that IgA-producing cells were driven by the gut microbiota and were primarily localized in the intestinal lamina propria of RaptorB−/− mice. Consistently, IgA produced in RaptorB−/− mice was functional in its ability to bind gut bacteria and contributed to maintaining gut microbiota α-diversity, although its repertoire was restricted compared with that of control mice. Our findings demonstrated a distinct population of IgA-producing cells that develop independently of mTORC1 and contribute to gut homeostasis, thereby distinguishing them from conventional IgM- and IgG-producing cells.
- 22 October 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (3) , 185-196
mTORC1-independent IgA production: a unique pathway for gut immune homeostasis
The mammalian target of rapamycin (mTOR) complex 1 (mTORC1) regulates various cellular processes, including immune responses. Previous studies have demonstrated that mTORC1 plays a crucial role in B cell differentiation and the production of IgM and IgG antibodies in response to foreign antigens. However, its role in steady-state antibody production remains poorly understood. In this study, we found that RaptorB−/− mice, which have a B cell-specific deletion of Raptor (an essential component of mTORC1), retained gut-associated IgA production. Conversely, IgM and IgG subclasses were virtually absent due to the loss of peripheral IgM+ mature B cells. We also found that IgA-producing cells were driven by the gut microbiota and were primarily localized in the intestinal lamina propria of RaptorB−/− mice. Consistently, IgA produced in RaptorB−/− mice was functional in its ability to bind gut bacteria and contributed to maintaining gut microbiota α-diversity, although its repertoire was restricted compared with that of control mice. Our findings demonstrated a distinct population of IgA-producing cells that develop independently of mTORC1 and contribute to gut homeostasis, thereby distinguishing them from conventional IgM- and IgG-producing cells.
- 8 October 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (3) , 172-184
Role of Group 2 innate lymphoid cells in intranasal sensitization-induced allergic rhinitis in mice
Cells of the innate immune system, specifically Group 2 innate lymphoid cells (ILC2s), play an important role in Type 2 inflammation. However, their involvement in allergic rhinitis remains unclear. Thus, in this study, we aimed to clarify the role of ILC2s and acquired immune responses in the onset of allergic rhinitis induced via intranasal mucosal sensitization with antigens in mice. Naive mice were intranasally administered antigens in the short term (4 consecutive days) or long term (21 consecutive days). The number of sneezes, serum-specific immunoglobulin E (IgE) levels, and eosinophil infiltration in the nasal mucosa were subsequently assessed. Short-term intranasal antigen administration to naive mice induced eosinophilic inflammation of the nasal mucosa in an acquired immune-independent and protease- and ILC2-dependent manner. Antigen-independent sneezing was caused by a calcium influx response via transient receptor potential vanilloid channels. In contrast, long-term intranasal mucosal sensitization with antigens led to the onset of allergic rhinitis. Furthermore, increased serum-specific IgE levels and sneezing frequency, as well as significant eosinophilic infiltration, were observed in the nasal mucosa. ILC2s in the nasal mucosa did not proliferate upon short-term stimulation with antigens but proliferated upon long-term stimulation, facilitating acquired immunity and allergic rhinitis onset. Our findings demonstrated that allergic inflammation is induced by the protease/IL-33/ILC2/IL-5 axis during the initiator phase. Acquired immunity induced by long-term sensitization and innate immunity facilitated by short-term sensitization together induce significant allergic inflammation and allergic rhinitis onset.
- 8 October 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (3) , 172-184
Role of Group 2 innate lymphoid cells in intranasal sensitization-induced allergic rhinitis in mice
Cells of the innate immune system, specifically Group 2 innate lymphoid cells (ILC2s), play an important role in Type 2 inflammation. However, their involvement in allergic rhinitis remains unclear. Thus, in this study, we aimed to clarify the role of ILC2s and acquired immune responses in the onset of allergic rhinitis induced via intranasal mucosal sensitization with antigens in mice. Naive mice were intranasally administered antigens in the short term (4 consecutive days) or long term (21 consecutive days). The number of sneezes, serum-specific immunoglobulin E (IgE) levels, and eosinophil infiltration in the nasal mucosa were subsequently assessed. Short-term intranasal antigen administration to naive mice induced eosinophilic inflammation of the nasal mucosa in an acquired immune-independent and protease- and ILC2-dependent manner. Antigen-independent sneezing was caused by a calcium influx response via transient receptor potential vanilloid channels. In contrast, long-term intranasal mucosal sensitization with antigens led to the onset of allergic rhinitis. Furthermore, increased serum-specific IgE levels and sneezing frequency, as well as significant eosinophilic infiltration, were observed in the nasal mucosa. ILC2s in the nasal mucosa did not proliferate upon short-term stimulation with antigens but proliferated upon long-term stimulation, facilitating acquired immunity and allergic rhinitis onset. Our findings demonstrated that allergic inflammation is induced by the protease/IL-33/ILC2/IL-5 axis during the initiator phase. Acquired immunity induced by long-term sensitization and innate immunity facilitated by short-term sensitization together induce significant allergic inflammation and allergic rhinitis onset.
- 30 August 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (1) , 41-55
The role of IL-4+ memory T cells in SARS-CoV-2 booster vaccination
Vaccines effectively stimulate protective immune responses in healthy individuals, but the precise roles of germinal center (GC) and follicular helper T (TFH) cells in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine responses are not fully understood. This study used a conditional loss-of-function mouse model to investigate antibody responses to the Wuhan spike protein, specifically eliminating newly developed TFH cells during either the primary or memory phase. Our findings demonstrated that TFH-mediated GC responses are essential for primary vaccination. However, after booster immunization, memory B-cell responses were effectively regulated through extrafollicular mechanisms, independent of TFH cells. Ablating IL-4 receptor signaling in B cells attenuated antibody production in both the primary and memory phases, highlighting the critical role of IL-4 for optimal humoral immunity. We identified a unique population of IL-4-expressing memory T (IL-4+Tm) cells, characterized by CD27, GATA3, and IRF4 expression, that is strongly associated with these extrafollicular memory B-cell responses, capable of neutralizing SARS-CoV-2 variants. Furthermore, Omicron-based booster immunization recovered the immunity against emerging variants under TFH-deficient conditions. These results suggest that IL-4+Tm cells are an alternative pathway to sustain memory responses when GC function is impaired, particularly in immunocompromised states. Our study advances the understanding of memory T-cell-mediated humoral responses to SARS-CoV-2, offering insights for future vaccine strategies.
- 30 August 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (1) , 41-55
The role of IL-4+ memory T cells in SARS-CoV-2 booster vaccination
Vaccines effectively stimulate protective immune responses in healthy individuals, but the precise roles of germinal center (GC) and follicular helper T (TFH) cells in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine responses are not fully understood. This study used a conditional loss-of-function mouse model to investigate antibody responses to the Wuhan spike protein, specifically eliminating newly developed TFH cells during either the primary or memory phase. Our findings demonstrated that TFH-mediated GC responses are essential for primary vaccination. However, after booster immunization, memory B-cell responses were effectively regulated through extrafollicular mechanisms, independent of TFH cells. Ablating IL-4 receptor signaling in B cells attenuated antibody production in both the primary and memory phases, highlighting the critical role of IL-4 for optimal humoral immunity. We identified a unique population of IL-4-expressing memory T (IL-4+Tm) cells, characterized by CD27, GATA3, and IRF4 expression, that is strongly associated with these extrafollicular memory B-cell responses, capable of neutralizing SARS-CoV-2 variants. Furthermore, Omicron-based booster immunization recovered the immunity against emerging variants under TFH-deficient conditions. These results suggest that IL-4+Tm cells are an alternative pathway to sustain memory responses when GC function is impaired, particularly in immunocompromised states. Our study advances the understanding of memory T-cell-mediated humoral responses to SARS-CoV-2, offering insights for future vaccine strategies.
- 21 March 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 37 (8) , 475-491
Single-cell multiomic analysis revealed the differentiation, localization, and heterogeneity of IL10+ Foxp3– follicular T cells in humans
Germinal center (GC) reactions are tightly regulated to generate high-affinity antibodies. Although IL10+ Foxp3– follicular T cells have recently been described as contributing to the suppression of GC reactions, their differentiation, localization, and heterogeneity remain incompletely understood. Additionally, it remains unclear whether IL10+ Foxp3– follicular T cells represent a transient status or an independent subset. To address these gaps, we performed integrative single-cell analysis of transcriptomes, epigenomes, surface proteomes, and TCR repertoires in human tonsillar CD4+ T cells. Unbiased clustering revealed IL10+ Foxp3– follicular T cells as a transcriptionally and epigenetically unique subset. This subset exhibited features of both T follicular helper (Tfh) and T regulatory type 1 (Tr1) cells, and accordingly, hereafter, we call them T follicular regulatory type 1 (Tfr1) cells. Analysis using imaging mass cytometry and spatial RNA-TCR sequencing demonstrated their presence within GCs in humans. Bioinformatic analysis suggested that Tfr1 cells differentiate from GC-Tfh cells upon strong TCR stimulation, a finding corroborated by mouse in vivo experiments and time-series single-cell RNA-TCR sequencing of human in vivo CD4+ T cells. Of note, our bioinformatic analysis suggested that Tfr1 cells receive strong TCR signals from ICOS-Lhigh GC-B cells, likely representing high-affinity GC-B cells. Finally, we show that Tfr1 cells acquire a resident memory phenotype following an effector phase. Together, our findings suggest that high-affinity ICOS-Lhigh GC-B cells transform follicular T cells from GC-Tfh cells to Tfr1 cells, which likely become memory cells and reside in the lymphoid organ to support effective antibody production.
- 21 March 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 37 (8) , 475-491
Single-cell multiomic analysis revealed the differentiation, localization, and heterogeneity of IL10+ Foxp3– follicular T cells in humans
Germinal center (GC) reactions are tightly regulated to generate high-affinity antibodies. Although IL10+ Foxp3– follicular T cells have recently been described as contributing to the suppression of GC reactions, their differentiation, localization, and heterogeneity remain incompletely understood. Additionally, it remains unclear whether IL10+ Foxp3– follicular T cells represent a transient status or an independent subset. To address these gaps, we performed integrative single-cell analysis of transcriptomes, epigenomes, surface proteomes, and TCR repertoires in human tonsillar CD4+ T cells. Unbiased clustering revealed IL10+ Foxp3– follicular T cells as a transcriptionally and epigenetically unique subset. This subset exhibited features of both T follicular helper (Tfh) and T regulatory type 1 (Tr1) cells, and accordingly, hereafter, we call them T follicular regulatory type 1 (Tfr1) cells. Analysis using imaging mass cytometry and spatial RNA-TCR sequencing demonstrated their presence within GCs in humans. Bioinformatic analysis suggested that Tfr1 cells differentiate from GC-Tfh cells upon strong TCR stimulation, a finding corroborated by mouse in vivo experiments and time-series single-cell RNA-TCR sequencing of human in vivo CD4+ T cells. Of note, our bioinformatic analysis suggested that Tfr1 cells receive strong TCR signals from ICOS-Lhigh GC-B cells, likely representing high-affinity GC-B cells. Finally, we show that Tfr1 cells acquire a resident memory phenotype following an effector phase. Together, our findings suggest that high-affinity ICOS-Lhigh GC-B cells transform follicular T cells from GC-Tfh cells to Tfr1 cells, which likely become memory cells and reside in the lymphoid organ to support effective antibody production.
- Open Access
- 17 March 2025
- Published by Springer Nature in Research Square
An interorgan neuroimmune circuit promotes visceral hypersensitivity
Visceral pain disorders such as interstitial cystitis/bladder pain syndrome (IC/BPS) and irritable bowel syndrome (IBS) often manifest concurrently in the bladder and colon. Yet, the mechanistic basis of such comorbidities and the transmission of neural hypersensitivity across organ systems has remained a mystery. Here, we identify a mast cell-sensory neuron circuit that initiates bladder inflammation and simultaneously propagates neural hypersensitivity to the colon in a murine model of IC/BPS. We unveil anatomic heterogeneity of mast cells in relation to nociceptors in the bladder and their critical dependence on Mas-related G protein-coupled receptor B2 (MrgprB2) to promote visceral hypersensitivity. Employing retrograde neuronal tracing, in vivo calcium imaging, and intersectional genetics, we uncover a population of polyorganic sensory neurons that simultaneously innervate multiple organs and exhibit functional convergence. Importantly, using humanized mice, we demonstrate that pharmacological blockade of mast cell-expressed MRGPRX2, the human ortholog of MrgprB2, attenuates both bladder pathology and colonic hypersensitivity. Our studies reveal evolutionarily conserved neuroimmune mechanisms by which immune cells can directly convey signals from one organ to another through sensory neurons, in the absence of physical proximity, representing a new therapeutic paradigm.
- 17 March 2025
- Published by Springer Nature in Research Square
Open AccessAn interorgan neuroimmune circuit promotes visceral hypersensitivity
Visceral pain disorders such as interstitial cystitis/bladder pain syndrome (IC/BPS) and irritable bowel syndrome (IBS) often manifest concurrently in the bladder and colon. Yet, the mechanistic basis of such comorbidities and the transmission of neural hypersensitivity across organ systems has remained a mystery. Here, we identify a mast cell-sensory neuron circuit that initiates bladder inflammation and simultaneously propagates neural hypersensitivity to the colon in a murine model of IC/BPS. We unveil anatomic heterogeneity of mast cells in relation to nociceptors in the bladder and their critical dependence on Mas-related G protein-coupled receptor B2 (MrgprB2) to promote visceral hypersensitivity. Employing retrograde neuronal tracing, in vivo calcium imaging, and intersectional genetics, we uncover a population of polyorganic sensory neurons that simultaneously innervate multiple organs and exhibit functional convergence. Importantly, using humanized mice, we demonstrate that pharmacological blockade of mast cell-expressed MRGPRX2, the human ortholog of MrgprB2, attenuates both bladder pathology and colonic hypersensitivity. Our studies reveal evolutionarily conserved neuroimmune mechanisms by which immune cells can directly convey signals from one organ to another through sensory neurons, in the absence of physical proximity, representing a new therapeutic paradigm.
- Open Access
- 14 February 2025
- Published by Springer Nature in Research Square
Atopic skin inflammation promotes systemic anaphylactic responses via IL-13 signaling in conventional dendritic cells.
Cutaneous allergen sensitization (CAS) underlies atopic dermatitis (AD) and leads to various allergic symptoms, including food allergy and anaphylaxis. IL-13 expression by T follicular helper T (TFH) has been reported to be involved in generating high-affinity IgE antibodies and causing systemic anaphylaxis.1, 2 However, the mechanisms by which IL-13 triggers IgE-mediated allergic responses remain poorly defined. In the present study, we elucidate the role of IL-13 in the CAS-mediated mechanism by which high-affinity IgE antibodies are produced when the same allergen is introduced at a distal site in the secondary sensitization. The CAS model system using mice lacking the cell lineage-specific IL-13 receptor (IL-13R) demonstrated that dendritic cells (DCs), but not T or B cells, are critical in the high-affinity IgE-mediated anaphylactic response. The IL-13 signal in type 2 conventional DCs (cDC2s) enhanced the expression of MHC class II and CD301b, which was essential for the recall of type 2 responses, inducing the production of high-affinity IgE antibodies. Similar IL-13R-expressing DCs were identified in allergic rhinitis and food allergy patients with a history of AD. These findings strongly suggest the importance of DC-specific IL-13 signaling in CAS-induced allergic reactions associated with the atopic march, which is common in human AD patients.
- 14 February 2025
- Published by Springer Nature in Research Square
Open AccessAtopic skin inflammation promotes systemic anaphylactic responses via IL-13 signaling in conventional dendritic cells.
Cutaneous allergen sensitization (CAS) underlies atopic dermatitis (AD) and leads to various allergic symptoms, including food allergy and anaphylaxis. IL-13 expression by T follicular helper T (TFH) has been reported to be involved in generating high-affinity IgE antibodies and causing systemic anaphylaxis.1, 2 However, the mechanisms by which IL-13 triggers IgE-mediated allergic responses remain poorly defined. In the present study, we elucidate the role of IL-13 in the CAS-mediated mechanism by which high-affinity IgE antibodies are produced when the same allergen is introduced at a distal site in the secondary sensitization. The CAS model system using mice lacking the cell lineage-specific IL-13 receptor (IL-13R) demonstrated that dendritic cells (DCs), but not T or B cells, are critical in the high-affinity IgE-mediated anaphylactic response. The IL-13 signal in type 2 conventional DCs (cDC2s) enhanced the expression of MHC class II and CD301b, which was essential for the recall of type 2 responses, inducing the production of high-affinity IgE antibodies. Similar IL-13R-expressing DCs were identified in allergic rhinitis and food allergy patients with a history of AD. These findings strongly suggest the importance of DC-specific IL-13 signaling in CAS-induced allergic reactions associated with the atopic march, which is common in human AD patients.